AK002: 1 mg/kg (first dose) followed by 3 mg/kg for 5 subsequent doses
160 patients 1:1 randomization placebo vs drug
016X protocol being submitted
Criteria
- ≥30 eos/hpf in 5 hpf in stomach
- PRO abdominal pian, nausea, and/or diarrha ≥3 for 2 weeks
- TSS ≥10 for 2 weeks
- Excl: Change in the dose of corticosteroids (systemic or topical), PPI, leukotrienes, or diet therapy within 4 weeks prior to screening.
